2006
Jin R, Rummel A, Binz T, Brunger AT.
Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity.
Nature 2006;444;1092-1095
Teichert M, Tatge H, Schoentaube J, Just I, Gerhard R.
Application of mutated Clostridium difficile toxin A for determination of Glucosyltransferase-dependent effects.
Inf Immun 2006;74(10);6006-6010
Genth H, Huelsenbeck J, Hartmann B, Hofmann F, Just I, Gerhard R.
Cellular stability of Rho-GTPases glucosylated by Clostridium difficile toxin B.
FEBS Lett 2006;580;3565-3569
Lee SH, Bigalke H.
Botulinumtoxin – Pharmakologie, Sicherheit und sekundäre Non-Response durch Antikörper
Neuropädiatrie in Klinik und Praxis 2006;5;52-56
Foster K, Bigalke H, Aoki R.
Botulinum Neurotoxin - From Laboratory to Bedside
Neurotoxicity Research 2006;9;133-140
Giesemann T, Jank T, Gerhard R, Maier E, Just I, Benz R, Aktories K.
Cholesterol-dependent pore formation of Clostridium difficile toxin A.
J Biol Chem 2006;281;10808-10815
Zürbig P, Renfrow MB, Schiffer E, Novak J, Walden M, Wittke S, Just I, Pelzig M, Neusüß C, Theodorescu D, Root KE, Ross MM, Mischak H.
Biomarker discovery by CE.MS enables sequences analysis via MS/MS with platform-independent separation.
Electrophoresis 2006;27(11);2111-21125
Molinari G, Rohde M, Wilde C, Just I, Aktories K, Chhatwal G.S.
Localization of the C3-like ADP-ribosyltransferase from Staphylococcus aureus during baterial invasion of mammalian cells.
Inf Immun 2006;74;3673-3677
Traub F, Jost M, Hess R, Schorn K, Menzel C, Budde P, Schulz-Knappe P, Lamping N, Pich A, Kreipe H, Tammen H.
Peptidomic analysis of breast cancer reveals a putative surrogate marker for estrogen receptor-negative carcinomas.
Lab Invest 2006;86;246-253
Stange DE, Radlwimmer B, Schubert F, Traub F, Pich A, Toedt G, Mendrzyk F, Lehmann U, Eils R, Kreipe H, Lichter, P.
High resolution genomic profiling reveals association of chromosomal aberrations on 1q and 16p with histologic and genetic subgroups of invasive breast cancer.
Clin Cancer Res 2006;12;345-52
Mahrhold S, Rummel A, Bigalke H, Davletov B, Binz T.
The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves.
FEBS Lett 2006;Apr3;580(8);2011-4
Rosales RL, Bigalke H, Dressler D.
Pharmacology of botulinum toxin: differences between type A preparations.
Eur J Neurol; 2006;13;2-10
Theodorescu D, Wittke S, Ross MM, Walden M, Conaway M, Just I, Mischak H, Frierson HF.
Discovery and validation of new protein biomarkers for urothelial cancer: a
prospective analysis.
Lancet Oncol 2006;7(3);230-40
Schröder O, Gerhard R, Stein J.
Die Antibiotika-assoziierte Diarrhö
Z Gastroenterol 2006;44(2);193-204